Dr. Saideep Bose, MD

Dr. Bose practices at Seattle Facial Plastic Surgery Center in Seattle, Washington.

Dr. Bose's NPI, 1922364942, was assigned on April 3, 2012. Dr. Bose graduated from Duke-NUS Graduate Medical School Singapore in 2012. Dr. Bose's Missouri license number on file is 2021004329.

Dr. Bose's primary practice is Seattle Facial Plastic Surgery Center, at 1101 Madison St, Seattle, WA 98104 in King County. The practice phone is (206) 624-6200.

Dr. Bose's primary practice is Seattle Facial Plastic Surgery Center in Seattle, Washington. Dr. Bose is also affiliated with Swedish First Hill Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Bose to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bose practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Bose's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Bose is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Bose's licenses on file in 5 states: Missouri, Alaska, Washington, Ohio and North Carolina.

Dmand AI lists aortic atherosclerois, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization, peripheral vascular disease and varicose veins among the conditions Dr. Bose treats.

CMS data shows 312 Medicare services from Dr. Bose across 10 procedure codes in 2024, for 336 Medicare patients. Medicare paid $20,842 for them.

CMS counts 336 Medicare patients who saw Dr. Bose in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 3.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bose's median patient age at 71, with 50% women.

In 2024, Dr. Bose wrote 26 Medicare Part D claims. 62% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $81 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Bose for performance year 2024, reported as part of a group. Dr. Bose accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bose as offering telehealth. CMS counts 11 procedures of leg revascularization (restoring blood flow) by Dr. Bose, more than 64% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Bose, published from 2012 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Blood Vessel Prosthesis Implantation, Endovascular Procedures and Anticoagulants. Dr. Bose has published most often in J Vasc Surg. Dr. Bose's most frequent co-authors are Matthew Russell Smeds, MD, Jae Sung Cho, MD and Ravi Narendra Ambani, MD.

Dmand AI links Dr. Bose to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Postthrombotic Syndrome and Venous Insufficiency.

CMS Open Payments shows 144 general payments to Dr. Bose from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. ShockWave Medical, Inc paid the most, $9,327.

Dr. Bose graduated from Duke-NUS Graduate Medical School Singapore in 2012.

Dr. Bose is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.